Table 1. Patient characteristics... | American Society of Hematology

Table 1.

Patient characteristics

Parameter	Hematological neoplasms	Controls	P
Parameter	N (%)	N (%)	P
N	32 156 (100)	32 156 (100)	—
Gender
Female	15 529 (48)	15 529 (48)	—
Male	16 987 (52)	16 987 (52)	—
Age, all (IQR)
Age distribution	70 (100), (59, 79)	70 (100), (59, 78)	>.9
10-49	5453 (16.95)	5453 (16.95)
50-69	10 255 (31.89)	10 255 (31.89)
70-89	15 688 (48.78)	15 688 (31.89)
90+	1120 (3.48)	1120 (3.48)
Influenza vaccine*	25 059 (77)	20 059 (77)	>.9
CDC risk score*			>.9
0-1	5822 (18)	5822 (18)
2-3	10 107 (31)	10 107 (31)
4+	16 587 (51)	16 587 (51)
Clinical parameters			>.9
Immunosuppression†	4614 (14)	2229 (6.9)	.001
Liver disease	2159 (6.6)	1267 (3.9)	.001
CKD	7912 (24)	6630 (20)	.001
Diabetes 2	10 027 (31)	10 960 (34)	.001
Hypertension	17 211 (53)	17 871 (55)	.001
Overweight‡	21 378 (66)	22 945 (71)	.001
Smoking	4451 (14)	5044 (16)	.001

Parameter	Hematological neoplasms	Controls	P
Parameter	N (%)	N (%)	P
N	32 156 (100)	32 156 (100)	—
Gender
Female	15 529 (48)	15 529 (48)	—
Male	16 987 (52)	16 987 (52)	—
Age, all (IQR)
Age distribution	70 (100), (59, 79)	70 (100), (59, 78)	>.9
10-49	5453 (16.95)	5453 (16.95)
50-69	10 255 (31.89)	10 255 (31.89)
70-89	15 688 (48.78)	15 688 (31.89)
90+	1120 (3.48)	1120 (3.48)
Influenza vaccine*	25 059 (77)	20 059 (77)	>.9
CDC risk score*			>.9
0-1	5822 (18)	5822 (18)
2-3	10 107 (31)	10 107 (31)
4+	16 587 (51)	16 587 (51)
Clinical parameters			>.9
Immunosuppression†	4614 (14)	2229 (6.9)	.001
Liver disease	2159 (6.6)	1267 (3.9)	.001
CKD	7912 (24)	6630 (20)	.001
Diabetes 2	10 027 (31)	10 960 (34)	.001
Hypertension	17 211 (53)	17 871 (55)	.001
Overweight‡	21 378 (66)	22 945 (71)	.001
Smoking	4451 (14)	5044 (16)	.001

CKD, chronic kidney disease; IQR, interquartile range.

See Patients and methods.

Immunosuppressive agents administered ≥2 times during the year prior to data extraction.

Overweight = body mass index .25.